Prism Pharmaceuticals

Prism Pharmaceuticals

Verified
Acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products

Launch date
Employees
Market cap
-
Net debt
-
Firm valuation
$60—90m (Dealroom.co estimates Jun 2013.)
King of Prussia Pennsylvania (HQ)
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/AN/ASeries A
$15mSeries B
N/A-
Not yet verified
$338m
Valuation: $338m
Acquisition
N/A$15mSeries C
Total Funding$30m

Recent News about Prism Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.